NCT05160506View on ClinicalTrials.gov

Corticosteroids to Treat Pancreatitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

March 6, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

April 30, 2027

Conditions
PancreatitisPancreatitis, AcuteCorticosteroidHydrocortisone
Interventions
DRUG

Hydrocortisone

Hydrocortisone is a steroid (corticosteroid) medication.

DRUG

Placebo

50ml of 0.9% NACL will serve as the placebo

Trial Locations (1)

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER